They showed that a low maspin protein expression was correlated with a higher incidence of tumor progression and emphasized a possible clinical role of this novel tumor suppressor gene in transitional cell carcinoma of the bladder [81]. This evidence concerns the gene SERPINB5 and bladder transitional cell carcinoma.